Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EULEXIN SALES RUNNING AT $ 3 MIL. PER MONTH, SCHERING-PLOUGH's GARNIER REPORTS; PROVENTIL TO TOP $ 200 MIL. IN 1989, GENERIC PROTECTION LIKELY
Dec 04 1989
•
By
The Pink Sheet
More from Archive
More from Pink Sheet